2004
Company Announces Share Repurchase Program INDIANAPOLIS - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that the company''s...
Fourth quarter highlights: Worldwide implantable defibrillator revenue of $396 million, up 30 percent Worldwide stent revenue of $202 million, down 17 percent; up 2 percent versus third quarter...
Guidant Receives FDA Approval Based on COMPANION Clinical Trial Data Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...
Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate...
Acquisition Positions Guidant to Enter New Therapy Area Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, will conduct a live webcast of its fourth quarter 2003 earnings conference...
Self-Expanding Stent Features New, More Accurate Delivery System Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today...
Dean of Duke University''s Pratt School of Engineering Will Stand for Re-Election by Guidant Shareholders in May Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the...
Live Webcast Available INDIANAPOLIS - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate in the JPMorgan...